Expression of PD-1 and PD-L1 in endometrial cancer: molecular and clinical significance

The Clinical and Pathological Characteristics of POLE-Mutated Endometrial Cancer: A Comprehensive Review

X Yao, M Feng, W Wang - Cancer Management and Research, 2024 - Taylor & Francis

Endometrial cancer shows high histological and molecular heterogeneity. The POLE
mutation is a significant molecular alteration in endometrial cancer, leading to the …

被引用次数：1 相关文章所有 6 个版本

[PDF] mdpi.com

Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection

N Galant, P Krawczyk, M Monist, A Obara… - International Journal of …, 2024 - mdpi.com

Endometrial cancer (EC) accounts for 90% of uterine cancer cases. It is considered not only
one of the most common gynecological malignancies but also one of the most frequent …

The PD-1/PD-L1 Gateway: Peripheral Immune Regulation in the Pathogenesis of Endometriosis

M Sobstyl, P Mertowska, S Mertowski… - International Journal of …, 2024 - mdpi.com

Endometriosis is a chronic inflammatory disease characterized by the presence of
endometrial-like tissue outside the uterine cavity, causing pain and infertility. Despite the …

[PDF] mdpi.com

FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features

DH Song, J Yang, CH Kim, MH Kim, JY Jo, JC Baek - Diagnostics, 2023 - mdpi.com

Background: Endometrial cancer (EC) has robust molecular diagnostic evidence that
correlates well with prognosis. In various types of cancers, FcRn has been identified as an …

[HTML][HTML] Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer

ST Waluyo, BA Tjokroprawiro, AS Rahaju - European Journal of Obstetrics …, 2024 - Elsevier

Objective To determine the effect of estrogen receptor (ER) on programmed death-ligand 1
(PD-L1) expression in type I endometrial cancer (EC). Material and Methods This …

[引用][C] Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer

I Petre, C Vernic, I Petre, CS Vlad, SI Sipos, A Bordianu… - Diseases, 2024 - MDPI

被引用次数：1 相关文章所有 6 个版本

[PDF] ejgo.net

[PDF][PDF] PD-L1 in a South African cohort of endometrial carcinomas: directions for the future

R Wadee, I Maposa - Eur. J. Gynaecol. Oncol, 2024 - oss.ejgo.net

Abstract The Programmed Death-1 (PD-1)/Programmed Death Ligand 1 (PD-L1) pathway is
the focus of numerous clinical trials on various tumours using immunotherapy. Endometrial …